Norbraylin is a benzopyran-2-one derivative that acts as a phosphodiesterase type 4 (PDE4) inhibitor; it can be used to inhibit PDE4 enzyme activity for the treatment of PDE4-related inflammatory diseases such as asthma and allergic rhinitis; additionally, it serves as a pharmaceutical intermediate in drug synthesis.